MicroHemp has announced it will present its "Genetics-as-a-Service" (GaaS) framework at this year's International Cannabis Business Conference (ICBC) in Berlin. The GaaS model focuses on providing medical operators with compliant, scalable genetic platforms designed for pharmaceutical environments. "Genetics are increasingly recognized not as a commodity, but as a core infrastructure element within regulated supply chains," says Dr. Marco Patrizio Bianco from Microhemp.
© Microhemp
Technical stability and compliance
Operating within a licensed framework, MicroHemp provides GMP/GACP-ready genetic programs. These services include sterile induction (genetic reboot), meristem-based clean-up, and long-term genetic banking. The objective is to supply fully sterile, pathogen-free plant material that meets the traceability and reproducibility requirements of pharmaceutical production.
On top of plant material, MicroHemp assists medical producers with the physical development of tissue culture laboratories. This includes workflow planning, equipment selection, and technical management to ensure labs function as integrated components of cultivation infrastructure.
© Microhemp
Addressing industry scalability
As European regulations become more mature and stricter, the industry faces a significant challenge in maintaining consistency at scale. According to Dr. Marco, one of the main issues is the lack of sterile propagation and validated tissue culture integration to ensure long-term pharmaceutical stability.
"One of the most critical challenges for the European industry today is achieving true genetic stability and reproducibility at scale," Marco notes. "Without sterile propagation systems and structured long-term planning, maintaining pharmaceutical consistency becomes increasingly difficult. The conversation is no longer simply about cultivation, it is about building reliable, traceable, and compliant production ecosystems."
For more information:
Microhemp S.r.l.
Via Giuseppe Verdi 131, 41019 Soliera (MO), Italy
+393351736178
[email protected]
microhemp.it
